Trademark: 97583720
Word
ANFYBI
Status
Registered
Status Code
700
Status Date
Tuesday, July 9, 2024
Serial Number
97583720
Registration Number
7436262
Registration Date
Tuesday, July 9, 2024
Mark Type
4
Filing Date
Thursday, September 8, 2022
Published for Opposition
Tuesday, April 23, 2024

Trademark Owner History
Ipsen Pharma S.A.S. - Original Registrant

Classifications
5 Pharmaceutical preparations for use in the prevention and the treatment of cancer, orphan diseases, immune disorders, liver diseases, biliary diseases, metabolic diseases, inflammatory diseases, urological diseases, disorders and diseases of the reproductive system, puberty diseases or disorders, gynecological disorders, fertility, acromegalia and tumors, hormonal disorders, endocrine disorders, connective tissue disease, blood diseases, gastrointestinal diseases and disorders, hemophilia, gastrointestinal bleeding disorders, neurological diseases, muscle disorders, bone disorders, skeletal disorders, neuromuscular disorders, cervical dystonia, cerebral palsy, spasticity, blepharospam, migraine, bladder pain syndrome, pain, glabellar lines, facial wrinkles, asymmetries and defects and conditions of the human skin; Pharmaceutical preparations containing notably botulinum toxin, botulinum toxin-haemagglutin complex, botulinum toxin fragments and other botulinum toxin derivatives for skin care and the treatment of neurological disorders; pharmaceutical preparations containing botulinum toxin with specified components of the toxin haemagglutin complex for skin care and the treatment of neurological disorders

Trademark Events
Sep 12, 2022
New Application Entered
Sep 14, 2022
New Application Office Supplied Data Entered
Jun 22, 2023
Assigned To Examiner
Jun 26, 2023
Non-Final Action Written
Jun 26, 2023
Non-Final Action E-Mailed
Jun 26, 2023
Notification Of Non-Final Action E-Mailed
Sep 19, 2023
Teas Response To Office Action Received
Feb 9, 2024
Assigned To Lie
Feb 9, 2024
Correspondence Received In Law Office
Feb 9, 2024
Teas/Email Correspondence Entered
Feb 28, 2024
Assigned To Examiner
Mar 1, 2024
Suspension Letter Written
Mar 1, 2024
Letter Of Suspension E-Mailed
Mar 1, 2024
Notification Of Letter Of Suspension E-Mailed
Mar 12, 2024
Teas Response To Suspension Inquiry Received
Mar 13, 2024
Correspondence Received In Law Office
Mar 13, 2024
Teas/Email Correspondence Entered
Mar 21, 2024
Approved For Pub - Principal Register
Apr 3, 2024
Notification Of Notice Of Publication E-Mailed
Apr 23, 2024
Published For Opposition
Apr 23, 2024
Official Gazette Publication Confirmation E-Mailed
Jul 9, 2024
Registered-Principal Register
Jul 9, 2024
Notice Of Registration Confirmation Emailed

Trademark Alertz updated from USPTO on 2030-01-24